“…Numerous intervention strategies to minimize the inflammatory tissue responses to neural implants have been proposed and/or investigated including device footprint size [44, 51, 52], electrode site size [44, 53], volumetric density across the device’s footprint [54, 55], strength [44, 56], compliance/flexibility [44, 57], elasticity/softness [58–61], electrical properties [62–66], device insertion speed [67, 68], tip shape[67], surface modifications [44, 69–71 and 109], and drug delivery [27–29, 72–79]. In particular, dexamethasone (Dex), an anti-inflammatory synthetic glucocorticoid, has been frequently used to reduce inflammation and the reactive tissue response around surgical implants [80, 81], and more recently for use with brain implants [27–29, 72–79, 82].…”